Authors: | Hashemzehi, Milad Naghibzadeh, Niloufar Asgharzadeh, Fereshteh Mostafapour, Asma Hassanian, Seyed Mahdi Ferns, Gordon A. Cho, William C. Avan, Amir Khazaei, Majid |
Title: | The therapeutic potential of losartan in lung metastasis of colorectal cancer |
Language (ISO): | en |
Abstract: | Colorectal cancer (CRC) is a common cancer with a high incidence rate. Components of the renin-angiotensin system (RAS) have been reported to be dysregulated in several malignancies including CRC. Here, we have explored the potential anti-metastatic effects of a RAS inhibitor, losartan, in an experimental model of lung metastasis in CRC. A murine model of lung metastasis of CRC was used, which involved the intravenous injection of CT26 cells via a tail vein. Four experimental groups comprised: an untreated group; a group that received 5-FU which was administered intraperitoneally; a losartan group that received a combination group that received 5-FU plus losartan . We evaluated the anti-inflammatory effects of losartan by histopathological method, and the measurement of oxidative or antioxidant markers including malondialdehyde (MDA) and total-thiols (T-SH) tissue levels, superoxide-dismutase (SOD) and catalase activity. We found that losartan inhibited lung metastasis of CRC and there was a reduction of the IL-6 expression level in the tissue sample. It was also associated with reduced levels of the anti-angiogenic factor Vascular endothelial growth factor (VEGF). Furthermore, we found that losartan induced oxidative stress as assessed by an elevation of MDA level, reduction of T-SH, SOD and catalase activities in lung tissue. Our findings demonstrated that losartan ameliorates angiogenesis, inflammation and the induction of oxidative stress via Angiotensin II type I receptor (AT1R). This may shine some lights on targeting the RAS pathway as a potential therapeutic approach in the treatment of metastatic CRC patients. |
Subject Headings: | Renin-angiotensin system Losartan Colorectal cancer Lung metastasis |
URI: | http://hdl.handle.net/2003/39878 http://dx.doi.org/10.17877/DE290R-21769 |
Publishers Link: | https://www.excli.de/index.php/excli/article/view/2093 |
Issue Date: | 2020-06-29 |
Rights link: | https://creativecommons.org/licenses/by/4.0/ |
Provenance: | IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund |
Citation: | Hashemzehi, M., Naghibzadeh, N., Asgharzadeh, F., Mostafapour, A., Hassanian, S. M., Ferns, G. A., Cho, W. C., Avan, A., & Khazaei, M. (2020). The therapeutic potential of losartan in lung metastasis of colorectal cancer. EXCLI Journal, 19, 927-935. https://doi.org/10.17179/excli2020-2093 |
Appears in Collections: | Original Articles 2020 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
excli2020-2093.pdf | DNB | 1.34 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License